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High titre stocks of replication-defective retroviral vectors are
generally prepared by stable introduction of cloned proviraJ DNA
into packaging cell lines that supply in-trans all the proteins
necessary for viral assembly (1). However, different vectors are
packaged with different efficiencies and the expression of
transgenes and activity of heterologous internal promoter elements
may vary widely, dependent upon poorly understood and often
ill-defined features of recombinant proviral structure (2).
Optimization and comparative screening of proviral structures
by isolation and selection of stable producer cell clones is thus
an extremely time consuming and labour intensive procedure.
A more rapid and simpler alternative for the preparation of high
titre retroviral stocks is the short-term production of virus via
transient transfection of packaging cells. This approach often
yields low viral titres due to the inefficiency of standard
transfection procedure such as the use of CaPO4-DNA
precipitates (3,4). However, methods have been recently
described for the transient production of high titre retroviral stocks
using CaPO4-DNA precipitates and Cos cells or other SV40
large T antigen expressing cells (5,6). Here we describe a simple
method using high efficiency Lipofectamine-mediated gene
transfer to transiently and reproducably prepare recombinant
retroviral vectors at titres in excess of 103 cfu/ml. Cultures of
the ecotropic packaging cell line Ampli-GPE (7) were seeded
in 60 mm dishes (1.3 X 104, cells/cm2) and 24 hours later cells
were transfected by exposure to Lipofectamine-DNA complexes
prepared according to the manufacturer (Gibco BRL, Paisley,
Scotland).
Cultures were incubated at 37°C for 6 hours in the presence
of 3 ml of Dulbecco's modified Eagle medium containing 10
/tg/ml of Lipofectamine and 2 /ig/ml of supercoiled plasmid
DNA. Under these conditions 20-30% of cells were stained
positively for /S-galactosidase activity (8) following transfection
with BAG plasmid containing the Lac-Z gene (3). Supernatants
from cells transfected with BAG or pBABE Neo retroviral vectors
(9) were collected after 72 hours, filtered through a 0.45 y.m filter
and stored at -70°C. Viral titres were determined by infecting
NIH 3T3 fibroblasts, that were seeded 18-22 hours before at
a concentration of lO'Vcm2, with various dilutions of the viral
stocks in the presence of 8 /ig/ml polybrene. The number of cells
expressing /3-galactosidase was counted 48 hours later in the case
of the BAG vector, while the number of G418 resistant colonies
Table 1. Retroviral production from Ampli-GPE cells after Lipofectamine-
mediated transfection
Expr No Plasmid Construct Recombinant
Retrovirus
Titre* (Mean
Helper virus titre*
± SD)
1
2
3
4
5
BAG
BAG
BAG
pBABE Neo
pBABE Neo
1.6X1O5 ± 0.3
2.2 xlO3 ± 0.5
2.OX1O5 ± 0.5
l.OxlO3 ± 0.3
1.2X1O5 ± 0.6
•Infectious titres (LacZ-positive cells or G418 resistant colonies/ml) were
determined as previously described (6). For helper virus determination, 300 /J
of undiluted viral stocks were tested.
was counted 12 days later for pBABE Neo. As shown in table
1, titres of greater than 105 were reproducibly obtained by
Lipofectamine-mediated gene transfer for both the BAG and
pBABE Neo vectors, which compares favourably with titres
obtained from stably-transfected clonal producer cells. To achieve
high and consistent titres of virus using the Lipofectamine
procedure we found it to be essential that the 5:1 (w/w) ratio
of lipid to DNA was precisely maintained as well as the
concentration of the cells (1.3 x lO'Vcm2) that had to be
accurately dispersed. The absence of helper virus in the transiently
produced stocks was confirmed by mobilization assay (1) using
3T3 fibroblasts that stably express an indicator previrus. Cultures
were passaged at high density for 7 days, supernatants were then
used to infect NTH 3T3 fibroblasts as described. In conclusion
the present method can be used to rapidly and conveniently
prepare large numbers of high titre, helper-free stocks of
recombinant retroviral vectors, thus allowing efficient screening
and characterisation of variant proviral structures and packaging
cell lines.
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